Dare Bioscience, Inc. — Director's Dealing 2016

Aug 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-08-22

Reporting Person: BELOFF GREGG (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-22	Stock Option (right to buy)	$1.14	A	75000	Acquired	2026-08-21	Common Stock (75000)	Direct

Footnotes

F1: This option was granted on August 22, 2016. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of August 22, 2016 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until August 22, 2018.